Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease. / Vestergaard, Mark B.; Iversen, Helle K.; Simonsen, Sofie Amalie; Lindberg, Ulrich; Cramer, Stig P.; Andersen, Ulrik B.; Larsson, Henrik B.W.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 43, No. 3, 2023, p. 460-475.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Vestergaard, MB, Iversen, HK, Simonsen, SA, Lindberg, U, Cramer, SP, Andersen, UB & Larsson, HBW 2023, 'Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease', Journal of Cerebral Blood Flow and Metabolism, vol. 43, no. 3, pp. 460-475. https://doi.org/10.1177/0271678X221139084

APA

Vestergaard, M. B., Iversen, H. K., Simonsen, S. A., Lindberg, U., Cramer, S. P., Andersen, U. B., & Larsson, H. B. W. (2023). Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease. Journal of Cerebral Blood Flow and Metabolism, 43(3), 460-475. https://doi.org/10.1177/0271678X221139084

Vancouver

Vestergaard MB, Iversen HK, Simonsen SA, Lindberg U, Cramer SP, Andersen UB et al. Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease. Journal of Cerebral Blood Flow and Metabolism. 2023;43(3):460-475. https://doi.org/10.1177/0271678X221139084

Author

Vestergaard, Mark B. ; Iversen, Helle K. ; Simonsen, Sofie Amalie ; Lindberg, Ulrich ; Cramer, Stig P. ; Andersen, Ulrik B. ; Larsson, Henrik B.W. / Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease. In: Journal of Cerebral Blood Flow and Metabolism. 2023 ; Vol. 43, No. 3. pp. 460-475.

Bibtex

@article{78ed77288a3045ab9ac77d7a6742b9f8,
title = "Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease",
abstract = "The healthy cerebral perfusion demonstrates a homogenous distribution of capillary transit times. A disruption of this homogeneity may inhibit the extraction of oxygen. A high degree of capillary transit time heterogeneity (CTH) describes that some capillaries have very low blood flows, while others have excessively high blood flows and consequently short transit times. Very short transit times could hinder the oxygen extraction due to insufficient time for diffusion of oxygen into the tissue. CTH could be a consequence of cerebral vessel disease. We examined whether patients with cerebral steno-occlusive vessel disease demonstrate high CTH and if elevation of cerebral blood flow (CBF) by administration of acetazolamide (ACZ) increases the cerebral metabolic rate of oxygen (CMRO2), or if some patients demonstrate reduced CMRO2 related to detrimental CTH. Thirty-four patients and thirty-one healthy controls participated. Global CBF and CMRO2 were acquired using phase-contrast MRI. Regional brain maps of CTH were acquired using dynamic contrast-enhanced MRI. Patients with impaired cerebrovascular reserve capacity demonstrated elevated CTH and a significant reduction of CMRO2 after administration of ACZ, which could be related to high CTH. Impaired oxygen extraction from CTH could be a contributing part of the declining brain health observed in patients with cerebral vessel disease.",
keywords = "Cerebral blood flow, cerebral hemodynamics, cerebrovascular disease, oxygen extraction fraction (OEF), small vessel disease",
author = "Vestergaard, {Mark B.} and Iversen, {Helle K.} and Simonsen, {Sofie Amalie} and Ulrich Lindberg and Cramer, {Stig P.} and Andersen, {Ulrik B.} and Larsson, {Henrik B.W.}",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",
year = "2023",
doi = "10.1177/0271678X221139084",
language = "English",
volume = "43",
pages = "460--475",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "SAGE Publications",
number = "3",

}

RIS

TY - JOUR

T1 - Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease

AU - Vestergaard, Mark B.

AU - Iversen, Helle K.

AU - Simonsen, Sofie Amalie

AU - Lindberg, Ulrich

AU - Cramer, Stig P.

AU - Andersen, Ulrik B.

AU - Larsson, Henrik B.W.

N1 - Publisher Copyright: © The Author(s) 2022.

PY - 2023

Y1 - 2023

N2 - The healthy cerebral perfusion demonstrates a homogenous distribution of capillary transit times. A disruption of this homogeneity may inhibit the extraction of oxygen. A high degree of capillary transit time heterogeneity (CTH) describes that some capillaries have very low blood flows, while others have excessively high blood flows and consequently short transit times. Very short transit times could hinder the oxygen extraction due to insufficient time for diffusion of oxygen into the tissue. CTH could be a consequence of cerebral vessel disease. We examined whether patients with cerebral steno-occlusive vessel disease demonstrate high CTH and if elevation of cerebral blood flow (CBF) by administration of acetazolamide (ACZ) increases the cerebral metabolic rate of oxygen (CMRO2), or if some patients demonstrate reduced CMRO2 related to detrimental CTH. Thirty-four patients and thirty-one healthy controls participated. Global CBF and CMRO2 were acquired using phase-contrast MRI. Regional brain maps of CTH were acquired using dynamic contrast-enhanced MRI. Patients with impaired cerebrovascular reserve capacity demonstrated elevated CTH and a significant reduction of CMRO2 after administration of ACZ, which could be related to high CTH. Impaired oxygen extraction from CTH could be a contributing part of the declining brain health observed in patients with cerebral vessel disease.

AB - The healthy cerebral perfusion demonstrates a homogenous distribution of capillary transit times. A disruption of this homogeneity may inhibit the extraction of oxygen. A high degree of capillary transit time heterogeneity (CTH) describes that some capillaries have very low blood flows, while others have excessively high blood flows and consequently short transit times. Very short transit times could hinder the oxygen extraction due to insufficient time for diffusion of oxygen into the tissue. CTH could be a consequence of cerebral vessel disease. We examined whether patients with cerebral steno-occlusive vessel disease demonstrate high CTH and if elevation of cerebral blood flow (CBF) by administration of acetazolamide (ACZ) increases the cerebral metabolic rate of oxygen (CMRO2), or if some patients demonstrate reduced CMRO2 related to detrimental CTH. Thirty-four patients and thirty-one healthy controls participated. Global CBF and CMRO2 were acquired using phase-contrast MRI. Regional brain maps of CTH were acquired using dynamic contrast-enhanced MRI. Patients with impaired cerebrovascular reserve capacity demonstrated elevated CTH and a significant reduction of CMRO2 after administration of ACZ, which could be related to high CTH. Impaired oxygen extraction from CTH could be a contributing part of the declining brain health observed in patients with cerebral vessel disease.

KW - Cerebral blood flow

KW - cerebral hemodynamics

KW - cerebrovascular disease

KW - oxygen extraction fraction (OEF)

KW - small vessel disease

U2 - 10.1177/0271678X221139084

DO - 10.1177/0271678X221139084

M3 - Journal article

C2 - 36369740

AN - SCOPUS:85142133540

VL - 43

SP - 460

EP - 475

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 3

ER -

ID: 338355210